Video Player is loading.

Suivant


NYU Study finds patients given Hydroxychloroquine + Zinc 44% less likely to die from COVID-19

Arrow Durfee
Arrow Durfee - 335 Vues
157
335 Vues
Publié le 18 May 2020 / Dans

Researchers at NYU's Grossman School of Medicine found patients given the antimalarial drug hydroxychloroquine along with zinc sulphate and the antibiotic azithromycin were 44 percent less likely to die from the coronavirus.

Montre plus
0 commentaires sort Trier par

Suivant